Search Results - Felix Hammann
- Showing 1 - 18 results of 18
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern by Verena Schöning, Evangelia Liakoni, Christine Baumgartner, Aristomenis K. Exadaktylos, Wolf E. Hautz, Andrew Atkinson, Felix Hammann
Published in Journal of Translational Medicine (2022-09-01)Get full text
Article -
11
-
12
Knowledge and perceptions of nicotine, smoking cessation and electronic nicotine delivery systems among physicians and pharmacists in a Swiss hospital group by Samuel E. Christen, Elisabetta Scanniello, Felix Hammann, Carla Meyer-Massetti, Reto Auer, Jean-François Etter, Evangelia Liakoni
Published in Tobacco Induced Diseases (2025-07-01)Get full text
Article -
13
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature by Vanessa Alexandra Buetler, Nada Agbariah, Deborah Pia Schild, Fabian D. Liechti, Anna Wieland, Nicola Andina, Felix Hammann, Johanna A. Kremer Hovinga
Published in Frontiers in Medicine (2022-05-01)Get full text
Article -
14
Predicting affinity and potency of new psychoactive substances at cannabinoid 1 receptor with explainable artificial intelligence by Verena Schöning, Gaia Alluisetti, Gaia Alluisetti, Katharina Elisabeth Grafinger, Daniel Pasin, Christophe P. Stove, Henrik Gréen, Henrik Gréen, Wolfgang Weinmann, Felix Hammann
Published in Frontiers in Pharmacology (2026-05-01)Get full text
Article -
15
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive <i>Staphylococcus aureus</i> Infections: A Prospective Cohort Study by Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, Adrian Egli, Stephan Moser, Vladimira Hinic, Richard Kuehl, Stefano Bassetti, Martin Siegemund, Katharina M. Rentsch, Laura Hermann, Verena Schöning, Felix Hammann, Parham Sendi, Michael Osthoff
Published in Antibiotics (2024-09-01)Get full text
Article -
16
Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-l... by Yvonne Kamau, Mercy Tuwei, Caroline Wanjiku, Kelly Ominde, Mwanajuma Ngama, Jonathan Karisa, Lawrence Babu, Martha Muturi, Mwaganyuma Mwatasa, Jane Adetifa, Charlotte Kern, Urs Duthaler, Felix Hammann, Regina Rabinovich, Carlos Chaccour, Marta Ferreira Maia
Published in International Journal of Infectious Diseases (2024-11-01)Get full text
Article -
17
UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract by Kevin Stritt, Beat Roth, Audrey Masnada, Felix Hammann, Damien Jacot, Sonia Domingos-Pereira, François Crettenand, Perrine Bohner, Isabelle Sommer, Emilien Bréat, Julien Sauser, Laurent Derré, Manuel Haschke, James J. Collins, John McKinney, Sylvain Meylan
Published in Trials (2024-10-01)Get full text
Article -
18
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin... by Carlos Chaccour, Aina Casellas, Felix Hammann, Paula Ruiz-Castillo, Patricia Nicolas, Julia Montaña, Mary Mael, Prashant Selvaraj, Urs Duthaler, Sigilbert Mrema, Mwaka Kakolwa, Issa Lyimo, Fredros Okumu, Achla Marathe, Roger Schürch, Eldo Elobolobo, Charfudin Sacoor, Francisco Saute, Kang Xia, Caroline Jones, Cassidy Rist, Marta Maia, N. Regina Rabinovich
Published in Trials (2023-02-01)Get full text
Article
